secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001140361-25-018697
Event type: other
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo Therapeutics raises ~$23M in underwritten public offering of common stock and warrants
--------------------------------------------------------------------------------

- Offering of 12.2M shares and pre-funded warrants for 34.4M shares, each with accompanying purchase warrant, at $0.50 unit price.
- Gross proceeds expected ~$23M, before underwriting discounts and expenses; closing expected May 14, 2025.
- Pre-funded warrants exercisable at $0.01 per share; purchase warrants at $0.75 per share, exercisable after six months for six years.
- Sangamo may force exercise of purchase warrants if stock price exceeds $2.75 for ten consecutive trading days after six months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000114036125018697/0001140361-25-018697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000114036125018697/ny20048472x3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-018697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer